Sinocelltech Group (SHSE:688520) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688520 Sinocelltech Group Ltd SHSE:688520
54 GF Score
Price ¥33.76
GF Value ¥36.52
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sinocelltech Group Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

SHSE:688520
54GF Score
Sinocelltech Group Ltd SHSE:688520
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sinocelltech Group (SHSE:688520) Overvalued in 2026?

Based on GuruFocus' analysis, Sinocelltech Group stock appears to be undervalued. The current stock price of ¥33.76 is trading 7.6% below its estimated GF Value™ of ¥36.52. GuruFocus considers Sinocelltech Group to be Fairly Valued.

Key valuation signals for SHSE:688520:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ¥36.52 vs. price of ¥33.76 (7.6% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinocelltech Group Business Description

Address Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, No. 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is one of Chin's biopharma companies specializing in biologics and vaccines. The company's therapeutic areas include oncology, immunology and inflammation, ophthalmology, and prophylactic vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The capabilities of the company include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up, protein purification development, and large scale production.
54GF Score

Get the complete analysis for SHSE:688520

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.76
Price
¥36.52
GF Value